| NAME |
METHYLPHENIDATE HCL (APTENSIO XR) 15MG CAP,SA |
| VA GENERIC NAME |
METHYLPHENIDATE |
| DOSAGE FORM |
CAP,SA |
| FDA MED GUIDE |
Methylphenidate_SA_Cap_(Generic)_(2020).pdf |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Schedule II Non-Narcotics |
| STRENGTH |
15 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| INACTIVATION DATE |
2020-06-10 00:00:00 |
| UNITS |
MG |
| NATIONAL FORMULARY NAME |
METHYLPHENIDATE CAP,SA |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
- COPAY END DATE: 2020-05-06 00:00:00
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2020-05-07 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
METHYLPHENIDATE (APTENSIO XR)15MG SA CAP |
| VA PRODUCT IDENTIFIER |
M1056 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
CAP |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4034464 |
| EFFECTIVE DATE/TIME |
-
- 2015-05-19 00:00:00
- STATUS: ACTIVE
-
- 2020-06-10 00:00:00
- STATUS: INACTIVE
|
